Depletion of the programmed death-1 receptor completely reverses established clonal anergy in CD4(+) T lymphocytes via an interleukin-2-dependent mechanism
| dc.contributor.author | Bishop, Kenneth D. | |
| dc.contributor.author | Harris, John E. | |
| dc.contributor.author | Mordes, John P. | |
| dc.contributor.author | Greiner, Dale L. | |
| dc.contributor.author | Rossini, Aldo A. | |
| dc.contributor.author | Czech, Michael P. | |
| dc.contributor.author | Phillips, Nancy E. | |
| dc.date | 2022-08-11T08:08:47.000 | |
| dc.date.accessioned | 2022-08-23T16:08:17Z | |
| dc.date.available | 2022-08-23T16:08:17Z | |
| dc.date.issued | 2009-02-24 | |
| dc.date.submitted | 2009-09-14 | |
| dc.identifier.issn | 1090-2163 (Electronic) | |
| dc.identifier.pmid | 19230866 | |
| dc.identifier.uri | http://hdl.handle.net/20.500.14038/32411 | |
| dc.description.abstract | Recent studies have implicated the cell surface receptor Programmed Death-1 (PD-1) in numerous models of T cell anergy, though the specific mechanisms by which the PD-1 signal maintains tolerance is not clear. We demonstrate that the depletion of PD-1 with siRNA results in a complete reversal of clonal anergy in the A.E7 T cell model, suggesting that the mechanism by which PD-1 maintains the anergic phenotype is a T-cell-intrinsic phenomenon, and not one dependent on other cell populations in vivo. We have also shown that the neutralization of IL-2 during restimulation abrogates the effect of PD-1 depletion, suggesting that tolerance mediated by PD-1 is wholly IL-2 dependent, and likewise intrinsic to the tolerized cells. | |
| dc.language.iso | en_US | |
| dc.relation | <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=19230866&dopt=Abstract">Link to Article in PubMed</a> | |
| dc.relation.url | http://dx.doi.org/10.1016/j.cellimm.2009.01.008 | |
| dc.rights | Citation: Cell Immunol. 2009;256(1-2):86-91. Epub 2009 Feb 23. <a href="http://dx.doi.org/10.1016/j.cellimm.2009.01.008">Link to article on publisher's site</a> | |
| dc.subject | Animals | |
| dc.subject | Antigens | |
| dc.subject | Antigens, Surface | |
| dc.subject | Apoptosis Regulatory Proteins | |
| dc.subject | inhibitors | |
| dc.subject | Base Sequence | |
| dc.subject | CD4-Positive T-Lymphocytes | |
| dc.subject | Cell Line | |
| dc.subject | Cell Proliferation | |
| dc.subject | Clonal Anergy | |
| dc.subject | Columbidae | |
| dc.subject | Cytochromes c | |
| dc.subject | DNA Primers | |
| dc.subject | Interleukin-2 | |
| dc.subject | Mice | |
| dc.subject | Mice, Inbred BALB C | |
| dc.subject | Phenotype | |
| dc.subject | RNA, Messenger | |
| dc.subject | RNA, Small Interfering | |
| dc.subject | Signal Transduction | |
| dc.subject | Transfection | |
| dc.subject | Transplantation Tolerance | |
| dc.subject | Laboratory and Basic Science Research | |
| dc.subject | Medicine and Health Sciences | |
| dc.title | Depletion of the programmed death-1 receptor completely reverses established clonal anergy in CD4(+) T lymphocytes via an interleukin-2-dependent mechanism | |
| dc.type | Journal Article | |
| dc.source.journaltitle | Cellular immunology | |
| dc.source.volume | 256 | |
| dc.source.issue | 1-2 | |
| dc.identifier.legacycoverpage | https://escholarship.umassmed.edu/gsbs_mdphd/11 | |
| dc.identifier.contextkey | 1004110 | |
| html.description.abstract | <p>Recent studies have implicated the cell surface receptor Programmed Death-1 (PD-1) in numerous models of T cell anergy, though the specific mechanisms by which the PD-1 signal maintains tolerance is not clear. We demonstrate that the depletion of PD-1 with siRNA results in a complete reversal of clonal anergy in the A.E7 T cell model, suggesting that the mechanism by which PD-1 maintains the anergic phenotype is a T-cell-intrinsic phenomenon, and not one dependent on other cell populations in vivo. We have also shown that the neutralization of IL-2 during restimulation abrogates the effect of PD-1 depletion, suggesting that tolerance mediated by PD-1 is wholly IL-2 dependent, and likewise intrinsic to the tolerized cells.</p> | |
| dc.identifier.submissionpath | gsbs_mdphd/11 | |
| dc.contributor.department | Department of Medicine, Division of Endocrinology and Metabolism | |
| dc.contributor.department | Department of Medicine, Diabetes Division | |
| dc.contributor.department | Program in Molecular Medicine | |
| dc.contributor.department | Graduate School of Biomedical Sciences, MD/PhD Program | |
| dc.source.pages | 86-91 |